SHARx Says Pharmacy Benefits Have Become a Major Spend Category With No Clear Owner
SHARx says pharmacy benefits have become one of the employer's largest healthcare spend, yet responsibility remains frag …
From Wrong Answers to Wrong Actions: The New Risk of Agentic AI in Life Sciences
As AI agents move deeper into regulated scientific workflows, AINGENS argues that autonomy must be bound by evidence, tr …
When PR Is Working: The Business Outcomes Disruptive Companies Should Demand
Forget what you think PR success looks like. It’s not about the noise or the number of mentions. For disruptive companie …
Wisner Baum's Lawsuits Challenge FDA Oversight of Spinal Cord Implants
Wisner Baum has filed state and federal lawsuits alleging spinal cord stimulators marketed as safe and effective for chr …
Four in Five Private Jet Buyers May Be Better Served with Other Products, FlyUSA Says
FlyUSA breaks down when charter, membership, jet cards, fractional access or ownership make sense, helping travelers avo …
Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics
Employers still rely too heavily on discounts and rebates to shortlist Pharmacy Benefit Managers (PBMs), according to US …
Good Employers Keep Choosing the Wrong PBM Because They Start With the Wrong Metrics
Employers still rely too heavily on discounts and rebates to shortlist Pharmacy Benefit Managers (PBMs), according to US …
How to Judge a PR Effort by Credibility, Not Clip Count
Clip counts don’t close deals. You’ve seen the endless reports filled with media mentions that don’t move the needle. Wh …
Trace3 Says AI's Production Gap Is Not a Technology Problem
As AI moves from pilots into production, Trace3 says the real test is no longer whether the technology works, but whethe …
Insurance Coverage Doesn't Guarantee Medication Access, SHARx Says
Prior authorizations, formulary exclusions, step therapy, and specialty pharmacy restrictions can delay treatment even w …
